Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.
2.

Strategies for rhEPO detection in sport.

Kazlauskas R, Howe C, Trout G.

Clin J Sport Med. 2002 Jul;12(4):229-35. Review.

PMID:
12131056
3.

Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.

Abellan R, Ventura R, Pichini S, Palmi I, Bellver M, Olive R, Pacifici R, Pascual JA, Zuccaro P, Segura J.

Int J Sports Med. 2007 Jan;28(1):9-15. Epub 2006 Jun 26.

PMID:
16804802
4.

Testing for recombinant erythropoietin.

Delanghe JR, Bollen M, Beullens M.

Am J Hematol. 2008 Mar;83(3):237-41.

5.

Detection of recombinant human erythropoietin in urine by isoelectric focusing.

Breidbach A, Catlin DH, Green GA, Tregub I, Truong H, Gorzek J.

Clin Chem. 2003 Jun;49(6 Pt 1):901-7.

6.

Effect of rhEPO administration on serum levels of sTfR and cycling performance.

Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R.

Med Sci Sports Exerc. 2000 Jul;32(7):1238-43.

PMID:
10912888
7.

False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise.

Beullens M, Delanghe JR, Bollen M.

Blood. 2006 Jun 15;107(12):4711-3. Epub 2006 Feb 21.

8.

Blood boosting and sport.

Ekblom BT.

Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Mar;14(1):89-98. Review.

PMID:
10932813
9.
10.

Erythropoietin test methods.

Breymann C.

Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Mar;14(1):135-45. Review.

PMID:
10932816
11.
12.

Applications and biomonitoring issues of recombinant erythropoietins for doping control.

Tsitsimpikou C, Kouretas D, Tsarouhas K, Fitch K, Spandidos DA, Tsatsakis A.

Ther Drug Monit. 2011 Feb;33(1):3-13. doi: 10.1097/FTD.0b013e31820032c4. Review.

PMID:
21099742
13.

Detection of recombinant human erythropoietin abuse in athletes utilizing markers of altered erythropoiesis.

Parisotto R, Wu M, Ashenden MJ, Emslie KR, Gore CJ, Howe C, Kazlauskas R, Sharpe K, Trout GJ, Xie M.

Haematologica. 2001 Feb;86(2):128-37.

14.

Recombinant erythropoietin and analogues: a challenge for doping control.

Pascual JA, Belalcazar V, de Bolos C, GutiƩrrez R, Llop E, Segura J.

Ther Drug Monit. 2004 Apr;26(2):175-9. Review.

PMID:
15228161
15.

[Recent advances in the detection of recombinant human erythropoiesis and its analogs in doping control].

Yang X, Pang N, Liao Y, Liu H.

Se Pu. 2008 Jul;26(4):413-6. Review. Chinese.

PMID:
18959234
16.

Development of reference ranges in elite athletes for markers of altered erythropoiesis.

Sharpe K, Hopkins W, Emslie KR, Howe C, Trout GJ, Kazlauskas R, Ashenden MJ, Gore CJ, Parisotto R, Hahn AG.

Haematologica. 2002 Dec;87(12):1248-57.

17.

Detection of darbepoetin alfa misuse in urine and blood: a preliminary investigation.

Morkeberg J, Lundby C, Nissen-Lie G, Nielsen TK, Hemmersbach P, Damsgaard R.

Med Sci Sports Exerc. 2007 Oct;39(10):1742-7.

PMID:
17909401
18.

Serum sTfR levels may indicate charge profiling of urinary r-hEPO in doping control.

Nissen-Lie G, Birkeland K, Hemmersbach P, Skibeli V.

Med Sci Sports Exerc. 2004 Apr;36(4):588-93.

PMID:
15064585
19.

Detection in blood and urine of recombinant erythropoietin administered to healthy men.

Wide L, Bengtsson C, Berglund B, Ekblom B.

Med Sci Sports Exerc. 1995 Nov;27(11):1569-76.

PMID:
8587495
20.

The asthmatic athlete, inhaled beta agonists, and performance.

McKenzie DC, Stewart IB, Fitch KD.

Clin J Sport Med. 2002 Jul;12(4):225-8.

PMID:
12131055
Items per page

Supplemental Content

Write to the Help Desk